Please login to the form below
Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?
In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy Watch patient record data, uptake of biosimilars remains relatively muted, with marked inconsistencies across the major European markets. With Enbrel biosimilar Benepali about to launch across EU, we ask what’s next for RA?
http://www.researchpartnership.com/news/2016/04/ft-are-biosimilars-the-answer-to-the-rising-cost-of-...
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Video
- Virtual Conference Live
Research Partnership
- Report
- Digital Health Tools - Physician Trends
Research Partnership
- Live webinar:
- Oncology landscape: How innovative market research methods can navigate you to success
Research Partnership
- Article:
- The disparity of patient experiences with Crohn’s Disease in Europe and Japan
Research Partnership
- Research Partnership’s MedTech Division appoints two Directors
- Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.
Research Partnership
- Webcast: Influencing HCP behaviours – Is now the perfect opportunity?
- Putting behavioural science at the forefront of market research
Research Partnership
